Emergent BioSolutions Inc.

About Emergent BioSolutions Inc.

Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent has been a go-to source for solving some of the most complex and critical challenges in public health. From initial process and analytical development, to clinical through commercial manufacturing supply, our experienced CDMO team can help guide your project successfully th...

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
Company types
Contact info

Products from Emergent BioSolutions Inc. (1)

  • Contract Development & Manufacturing (CDMO)

    Product Contract Development & Manufacturing (CDMO)

    Our capabilities include: • Development Services: Process, Analytical and Formulation Development, and Non-GMP Lab-Scale Manufacturing • Drug Substance: Upstream Manufacturing and Downstream Processing • Drug Product: Clinical and Commercial Manufacturing, Drug Product cGMP Lyophiliza...

Emergent BioSolutions Inc. Resources (4)

  • News Emergent to manufacture Humanigen COVID-19 therapeutic

    The CDMO gears up for rapid deployment of its clinical-to-commercial manufacturing operations for its seventh collaboration to help deliver COVID-19 treatments
  • Video Women in Leadership Forum

    This year the Women in Leadership Forum will discuss why empathy is the key leadership skill required to future-proof our workplaces and create an environment where everybody can fulfil their full potential. Hear from senior leaders across the pharma supply chain as they share a defining moment from their own leadership journey that demonstrates the importance of being an empathic leader. Connect with like-minded professionals as we take a close look at our own biases and how they unconsciously affect our day-to-day perspective of others during a speed networking session that follows the storytelling session. This presentation aired as part of the CPHI Festival of Pharma
  • News Empathy is the key to successful leadership: Women in Leadership Forum

    Female life sciences leaders share their experiences and discuss the skills and attributes needed these days to become a successful leader and empower teams
  • News Emergent BioSolutions signs 5-year manufacturing agreement for J&J’s lead COVID-19 vaccine candidate

    The CDMO produce drug substance at large scale for commercial manufacturing with the first 2 years valued at approximately $480 million.